MoneyWorks4Me

Glenmark Pharmaceuticals informs about analyst meet

21 Sep 2026 Evaluate
Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1846.90
Dr. Reddys Labs. 1212.85
Cipla 1369.60
Lupin 2122.95
Zydus Lifesciences 1172.50
View more..